rybelsus 14mg tablet

Rybelsus 14 mg Tablet – Product Description Rybelsus 14 mg Tablet contains semaglutide 14 mg, an oral GLP-1 receptor agonist used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It works by enhancing insulin release when blood glucose is elevated, reducing glucose production by the liver, and slowing gastric emptying. Key Benefits Helps improve blood glucose control in type 2 diabetes. May help reduce appetite and body weight as part of treatment, although its approved indication is diabetes management. Convenient once-daily oral tablet. The 14 mg strength is generally used after gradual dose escalation when additional glycemic control is required. How to Take Rybelsus should generally be taken once daily on an empty stomach, with a small amount of plain water. Wait at least 30 minutes before eating, drinking other beverages, or taking other oral medicines. The tablet should be swallowed whole and should not be crushed, split, or chewed. Common Side Effects Possible side effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and decreased appetite. Serious adverse effects can occur, so medical supervision is important. Important Safety Information Rybelsus is a prescription medicine. It should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients should also discuss pancreatitis, diabetic retinopathy, kidney problems, and other medical conditions with their doctor before treatment. Disclaimer: This description is for informational and product-content purposes only. Rybelsus 14 mg should be used strictly according to a doctor's prescription and advice.